These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7617108)

  • 1. Drug interaction between midecamycin and cyclosporin.
    Finielz P; Mondon JM; Chuet C; Guiserix J
    Nephron; 1995; 70(1):136. PubMed ID: 7617108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of a new macrolide, midecamycin on theophylline pharmacokinetics (author's transl)].
    Lavarenne J; Paire M; Talon O
    Therapie; 1981; 36(4):451-6. PubMed ID: 7292428
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of josamycin on plasma cyclosporine levels.
    Kreft-Jais C; Billaud EM; Gaudry C; Bedrossian J
    Eur J Clin Pharmacol; 1987; 32(3):327-8. PubMed ID: 3595708
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of interaction between cyclosporine and spiramycin.
    Birmele B; Lebranchu Y; Beliveau F; Rateau H; Furet Y; Nivet H; Bagros P
    Transplantation; 1989 May; 47(5):927-8. PubMed ID: 2718250
    [No Abstract]   [Full Text] [Related]  

  • 5. The in vitro activity of Midecamycin against various Vibrio species.
    Bonang G; Surjawidjaja JE; Santoso US
    Jpn J Exp Med; 1975 Feb; 45(1):43-5. PubMed ID: 1228226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteriostatic activity and salivary and blood protein interactions of midecamycin, a macrolide of dental importance].
    Pase U; Ceretti G; Perissinotto C
    G Stomatol Ortognatodonzia; 1985; 4(2):56-8. PubMed ID: 3914976
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of spiramycin on plasma cyclosporin A concentrations in heart transplant patients.
    Guillemain R; Billaud E; Dreyfus G; Amrein C; Kitzis M; Jebara VA; Kreft-Jais C
    Eur J Clin Pharmacol; 1989; 36(1):97-8. PubMed ID: 2645146
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between cyclosporine A and midecamycin.
    Alfonso I; Alcalde G; García-Sáiz M; de Cos MA; Mediavilla A
    Eur J Clin Pharmacol; 1997; 52(1):79-80. PubMed ID: 9143873
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of midecamycin against Staphylococcus aureus.
    Peng CF; Chen TS
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Mar; 12(1):32-3. PubMed ID: 583273
    [No Abstract]   [Full Text] [Related]  

  • 10. [Midecamycin activity against aerobic and anaerobic bacteria].
    Dubini F; Balsari A
    G Ital Chemioter; 1985; 32(3):539-44. PubMed ID: 3836904
    [No Abstract]   [Full Text] [Related]  

  • 11. [Absence of interaction between spiramycin and antipyrine].
    Descotes J; Simonet R; Evreux JC
    Presse Med; 1986 Jul 5-12; 15(27):1283. PubMed ID: 2945187
    [No Abstract]   [Full Text] [Related]  

  • 12. [Macrolides and theophylline: absence of a josamycin-theophylline interaction].
    Ruff F; Santais MC; Chastagnol D; Huchon G; Durieux P
    Nouv Presse Med; 1981 Jan; 10(3):175. PubMed ID: 7220321
    [No Abstract]   [Full Text] [Related]  

  • 13. [Theophylline and antibiotics. Absence of interaction with josamycin].
    Ruff F; Prosper M; Pujet JC
    Therapie; 1984; 39(1):1-6. PubMed ID: 6463939
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use and evaluation of 9,3"-di-0-acetyl midecamycin (MOM) in oral surgery].
    Satoh T; Sugiura Y; Fujiwara H; Suzuki M; Takahashi K; Saigusa F; Nishida K; Hisano Y
    Shigaku; 1982 Jun; 70(1):126-36. PubMed ID: 6985345
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of midecamycin acetate on intestinal bacterial flora of children, and results of clinical study on midecamycin acetate in the treatment of mycoplasma pneumonia].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Yukizane S; Suzuki K; Takajo N; Araki H; Kawano Y; Matsuura S; Imai S; Yuasa T; Tanaka Y; Tsugawa S; Nagayama K; Yamamoto M; Komatsu Y; Tanaka C; Matsuyama M; Koga T; Shiotsuki K; Kinoshita S; Haraguchi K; Matsuo H; Imuta F; Ohta M; Kubota K; Ichikawa K; Harada Y; Nakamura M
    Jpn J Antibiot; 1982 Nov; 35(11):2491-529. PubMed ID: 6763083
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of midecamycin sensitivity disc (author's transl)].
    Kanazawa Y; Kuramata T
    Jpn J Antibiot; 1976 Feb; 29(2):178-83. PubMed ID: 1263344
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug points. Probable interaction between cyclosporin A and low dose ticlopidine.
    Verdejo A; de Cos MA; Zubimendi JA; López-Lázaro L
    BMJ; 2000 Apr; 320(7241):1037. PubMed ID: 10764363
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriological evaluation of midecamycin acetate and its metabolites.
    Yoshida T; Watanabe T; Shomura T; Someya S; Okamoto R; Ishihara S; Miyauchi K; Kazuno Y
    Jpn J Antibiot; 1982 Jun; 35(6):1462-74. PubMed ID: 6982352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of midecamycin, a new macrolide antibiotic.
    Salhi A; Vindel JA; Brunaud M; Berceaux G; Marin A; Wuatelet C
    G Ital Chemioter; 1977; 24(1-2):67-76. PubMed ID: 308022
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the effects of midecamycin acetate and azithromycin on gastrointestinal motility in man.
    Sifrim D; Matsuo H; Janssens J; Vantrappen G
    Drugs Exp Clin Res; 1994; 20(3):121-6. PubMed ID: 7956719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.